Join
Live feed
·
INSIDERFilingvia Quantisnow
Zevra Therapeutics Inc. logo

Chief Legal & Compliance Thompson Rahsaan sold $20,272 worth of shares (1,794 units at $11.30) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 48,125 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ZVRA· Zevra Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ZVRA (Zevra Therapeutics Inc.) and more on Quantisnow.